Kauno veterinarijos vaistinė, UAB - financials and debts
Company age: 32 y. 8 mo.
Kauno veterinarijos vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 89,718 | 74,955 | 65,674 | 69,561 | 65,061 | 85,615 | 102,890 | 107,415 |
| Profit before tax | 142 | 1,732 | -4,417 | -3,869 | -9,901 | 3,925 | 8,512 | 7,366 |
| Net profit | 142 | 1,732 | -4,417 | -3,869 | -9,901 | 3,925 | 8,512 | 7,366 |
| Equity | 9,218 | 10,950 | 6,533 | 2,664 | -7,236 | -3,311 | 5,202 | 12,567 |
| Liabilities | 12,016 | 6,738 | 9,100 | 7,018 | 14,184 | 21,242 | 20,002 | 20,118 |
| Non-current assets | 2,523 | 2,357 | 2,191 | 2,025 | 1,860 | 1,694 | 1,549 | 1,444 |
| Current assets | 18,711 | 15,331 | 13,442 | 7,657 | 5,088 | 16,237 | 23,655 | 31,241 |
| Total assets | 21,234 | 17,688 | 15,633 | 9,682 | 6,948 | 17,931 | 25,204 | 32,685 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 7,927 | 10,820 | 9,502 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +18.7% | -16.5% | -12.4% | +5.9% | -6.5% | +31.6% | +20.2% | +4.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.7% | 9.8% | -28.3% | -40.0% | -142.5% | 21.9% | 33.8% | 22.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 1.5% | 15.8% | -67.6% | -145.2% | - | - | 163.6% | 58.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.2% | 2.3% | -6.7% | -5.6% | -15.2% | 4.6% | 8.3% | 6.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.2% | 2.3% | -6.7% | -5.6% | -15.2% | 4.6% | 8.3% | 6.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.3 | 0.6 | 1.4 | 2.6 | - | - | 3.8 | 1.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 29,906 | 24,985 | 21,891 | 23,187 | 21,687 | 28,538 | 34,297 | 35,805 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Kauno veterinarijos vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2021-11-16 | 2021-11-21 | 101.38 |
Kauno veterinarijos vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-29 | 2026-02-03 | 1.1 |
| 2026-01-01 | 2026-01-23 | 1.1 |
| 2025-12-01 | 2025-12-20 | 1.1 |
| 2025-11-28 | 2025-11-30 | 1.86 |
| 2025-10-30 | 2025-11-24 | 1.86 |
| 2025-10-17 | 2025-10-24 | 1.86 |
| 2025-10-02 | 2025-10-16 | 360.99 |
| 2025-09-28 | 2025-10-01 | 360.0 |
| 2025-09-19 | 2025-09-22 | 360.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Kauno veterinarijos vaistine, UAB, code 133923074, is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, the company generated €107.4K in revenue and €7.4K in net profit, corresponding to a 6.9% profit margin. Revenue increased by 4.4% year on year and by 25.5% over two years, showing a steady upward trend. Profit improved from €3.9K in 2023 to €8.5K in 2024, before easing in 2025 while remaining clearly positive. The balance sheet also strengthened: total assets reached €32.7K in 2025, compared with €25.2K in 2024 and €17.9K in 2023. Equity moved from a negative €3.3K in 2023 to €5.2K in 2024 and €12.6K in 2025, while liabilities were stable at about €20K. Long-term assets remained small at €1.4K, with most assets in short-term items. Key ratios for 2025 show solid efficiency, including ROE of 58.6%, ROA of 22.5%, debt-to-equity of 1.60 and asset turnover of 3.29x. Revenue per employee was €35.8K.